Oxazolidinone structure-activity relationships leading to linezolid.
about
Inhibition of mammalian mitochondrial protein synthesis by oxazolidinonesCurrent updates on oxazolidinone and its significanceResistance to linezolid caused by modifications at its binding site on the ribosomeDesign of O -Acetylserine Sulfhydrylase Inhibitors by Mimicking NatureRecent advances on halohydrin dehalogenases-from enzyme identification to novel biocatalytic applicationsTargeting Antibiotic ResistanceA Porous Metal-Organic Framework Assembled by [Cu30] Nanocages: Serving as Recyclable Catalysts for CO2 Fixation with AziridinesIn Situ Generated Zinc(II) Catalyst for Incorporation of CO2 into 2-Oxazolidinones with Propargylic Amines at Atmospheric Pressure.An Experimental and Theoretical Study on the Unexpected Catalytic Activity of Triethanolamine for the Carboxylative Cyclization of Propargylic Amines with CO2.New small-molecule synthetic antimycobacterials.Motualevic acids and analogs: synthesis and antimicrobial structure-activity relationshipsThe evolving role of chemical synthesis in antibacterial drug discovery.Singly modified amikacin and tobramycin derivatives show increased rRNA A-site binding and higher potency against resistant bacteria.RNA as a drug target: the case of aminoglycosides.Syntheses and biological studies of novel spiropiperazinyl oxazolidinone antibacterial agents using a spirocyclic diene derived acylnitroso Diels-Alder reaction.Design, Synthesis, and Identification of Silicon Incorporated Oxazolidinone Antibiotics with Improved Brain Exposure.Novel approaches to developing new antibiotics for bacterial infections.Syntheses and biological evaluation of new cephalosporin-oxazolidinone conjugates.Advances in MRSA drug discovery: where are we and where do we need to be?Bioactive compounds from marine bacteria and fungi.Recent advances in the chemistry and biology of naturally occurring antibiotics.Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps.Antibacterial oxazolidinones: emerging structure-toxicity relationships.The oxazolidinones: past, present, and future.Antituberculosis drug research: a critical overview.Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.The anti-tuberculosis agents under development and the challenges ahead.Total synthesis of leopolic acid A, a natural 2,3-pyrrolidinedione with antimicrobial activity.Synthesis of oxazolidinones: rhodium-catalyzed C-H amination of N-mesyloxycarbamates.Novel Oxazolidinone Antibacterial Analogues with a Substituted Ligustrazine C-ring Unit.Recent Advances in the Rational Design and Optimization of Antibacterial Agents.Using bacterial genomes and essential genes for the development of new antibiotics.Synthesis of novel 3-benzyl-2-phenyl-4(5H)-(substituted phenylhydrazino)-1, 3-oxazolidines and their antihyperglycemic activity.A brief history of antibiotics and select advances in their synthesis.Effective in silico prediction of new oxazolidinone antibiotics: force field simulations of the antibiotic-ribosome complex supervised by experiment and electronic structure methods.Inhibition of Streptococcus mutans biofilm formation, extracellular polysaccharide production, and virulence by an oxazole derivative.In vitro antibacterial activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457.Structure-activity relationships of diverse oxazolidinones for linezolid-resistant Staphylococcus aureus strains possessing the cfr methyltransferase gene or ribosomal mutations.trans-4-(1-Naphth-yl)-2-oxo-1,3-oxazolidine-5-carboxylic acid.4,5-Disubstituted oxazolidinones: High affinity molecular effectors of RNA function.
P2860
Q24548260-009E2EFC-548A-4BA2-820E-C5537F80F3CFQ26995628-05A21FE4-9BCB-41CF-B7BC-183E95B60F6CQ27006772-5B7D7976-EA73-43A6-8A7C-4D703F8367CEQ27658287-B8C3038D-A597-44E7-949C-ADFD49C8DCC2Q28072611-BCEFBF29-C182-41A0-B63B-2C198D9B2467Q28078130-939B519B-550E-41FB-979E-F80BDF6D7798Q28595694-319D7903-155B-4381-8C34-8802B30E47AAQ33469269-9B5B4F43-993E-4054-A620-D363D919597CQ33469968-940BB3AD-A6E3-4EB1-A23D-D1608D775A51Q33836780-D5BE4879-B21C-43BA-B929-8CCFB76A0106Q33976409-0E3B26EE-AE95-47C5-B017-AD8D68B0D9FFQ34427652-A1E5B0C2-B5EC-4B11-AF97-FD81F3946004Q34982853-C143DEDE-9F23-4EB0-808E-5AA714B9F691Q35549370-E0EAF8D1-B69A-499E-8BD1-27CEF3CC0EA3Q35997992-1FB5A2C7-9668-4356-B876-3CFD472B72EDQ36281035-B52C74AD-7CED-407B-B989-D395ABF84C46Q36358643-CF6EC15E-A49F-4F28-8362-2688E88FFD72Q36798120-32DD9E0A-B439-44D9-B2C3-459C186A737BQ37112508-49B8C1D6-7384-49B3-BF41-523426BA55D5Q37274675-D8DBFC09-1399-429A-A595-AFDEDF3CE938Q37313939-8042F621-2DD9-4092-84D9-132415AFDF03Q37339287-05BE21A1-BC9D-4570-AFE4-6D154829B96DQ37747401-3E657F71-4719-4E4B-A70B-7FCC3C1D2B4AQ37970719-2BCCD70F-0F41-4FEF-809C-A0E67A129187Q38012651-CCB6FA3D-3689-49F5-9A84-630AC00DA50BQ38352171-70B7544B-A4CD-48BE-B377-CB37EC920BDEQ38617197-E1669B2E-6DF7-44EE-8098-457405CE37CAQ38828014-92D59598-9F88-493F-B9BC-9FC22BD8C693Q38830834-101DEA6E-F218-447B-9B71-B230C8CBFD57Q38910257-8B96F705-6A0B-4631-824C-18682C053D71Q38958278-02659EFC-18B9-4611-83C3-AB78B28A4152Q39035296-17A49758-AE9F-4339-A8CE-F79D7796C3BCQ39151175-11D4910F-CB96-440F-A6AA-E0370615AF65Q39414195-0E1E7744-F98A-4266-8F0D-6B1061E92FAAQ39657879-64ED0273-D55E-40F5-A5D3-D827B3E1E241Q40364785-01D74AEB-D8BD-4DF0-BE2E-273B45DC5D28Q41788543-B9A260BB-FFFB-4360-8AB7-A9C904C2754EQ41862729-48C17495-AFA8-4476-9C60-CA40E4682380Q41869502-F1955367-E971-4EF6-9895-D7579267C5F1Q42015508-BF040B21-DE35-4E63-824F-7818A555D543
P2860
Oxazolidinone structure-activity relationships leading to linezolid.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Oxazolidinone structure-activity relationships leading to linezolid.
@ast
Oxazolidinone structure-activity relationships leading to linezolid.
@en
Oxazolidinone structure-activity relationships leading to linezolid.
@nl
type
label
Oxazolidinone structure-activity relationships leading to linezolid.
@ast
Oxazolidinone structure-activity relationships leading to linezolid.
@en
Oxazolidinone structure-activity relationships leading to linezolid.
@nl
prefLabel
Oxazolidinone structure-activity relationships leading to linezolid.
@ast
Oxazolidinone structure-activity relationships leading to linezolid.
@en
Oxazolidinone structure-activity relationships leading to linezolid.
@nl
P356
P1476
Oxazolidinone structure-activity relationships leading to linezolid.
@en
P2093
Charles W Ford
Michael R Barbachyn
P304
P356
10.1002/ANIE.200200528
P407
P577
2003-05-01T00:00:00Z